AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting from pertuzumab
Prof Gordon McVie provides highlights from ecancer for September 2016:
Video
Future Horizons in Lung Cancer
e-learning
Palliative care e-learning course for healthcare professionals in India
Journal
Adoptive cell therapy and modulation of the tumour microenvironment: new insights from ASCO 2016
Clinical Study: Is blue dye still required during sentinel lymph node biopsy for breast cancer?
VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions
Outcome of radical prostatectomy in primary circulating prostate cell negative prostate cancer
AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting from pertuzumab
Insights into germline genetic screening of breast cancer patients
Choosing Wisely for young women with breast cancer: Radiotherapy
ESMO 2024: Optimising the personalisation of prostate cancer treatment
ASCO 2024: Lung cancer highlights
Best practice in HRRm testing in patients with metastatic prostate cancer
Clinical behaviour of breast cancer in young BRCA carriers and prognostic impact of the timing of genetic testing
Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI
Choosing Wisely in radiology Tanzania